OLX10010

DRUG2 trials

Sponsors

Olix Pharmaceuticals, Inc.

Conditions

Cicatrix, HypertrophicHypertrophic Scar

Phase 1

A Study to Evaluate Safety and PK Profiles of OLX10010 in Healthy Subjects

CompletedNCT03569267

Olix Pharmaceuticals, Inc.Cicatrix, Hypertrophic

Start: 2018-05-21End: 2019-06-27Updated: 2019-08-08

Phase 2

Study to Evaluate Efficacy of OLX10010 in Reducing Recurrence of Hypertrophic Scarring After Scar Revision Surgery

CompletedNCT04877756

Olix Pharmaceuticals, Inc.Hypertrophic Scar

Start: 2021-08-19End: 2023-07-12Updated: 2024-02-21